When the Joint United Nations Programme on HIV/AIDS (UNAIDS) presented its Special Report, United to End AIDS, on July 27, 2026, at the 26th International AIDS Conference in Rio de Janeiro, Brazil, its message was clear: the world has the tools to end AIDS, but dwindling financial support could reverse decades of progress.
For years, the global HIV response was driven by scientific breakthroughs from lifesaving antiretroviral therapy to innovative prevention methods such as pre-exposure prophylaxis (PrEP). Today, UNAIDS says the biggest obstacle is no longer medicine but financing.
“The era of relying on international aid is over. Countries cannot wait and they cannot go backwards. The world must urgently fix the broken financial system and accelerate debt restructuring so that governments can invest in what matters most the health, education and futures of their people,” UNAIDS Executive Director Winnie Byanyima said while launching the report.
The warning comes at a time when global HIV funding is shrinking. According to UNAIDS, international financing for HIV programmes dropped by 18 percent in 2025, from US$8.8 billion in 2024 to US$7.3 billion the lowest level in nearly two decades.
Despite remarkable scientific progress, HIV continues to claim lives. The report estimates that 1.2 million people acquired HIV in 2025, while 570,000 people died from AIDS-related illnesses. Nearly 41 million people are currently living with HIV worldwide, and about 9 million are still not accessing lifesaving treatment.
UNAIDS warns that if current funding trends continue, the world could see more than three million additional HIV infections by 2030, putting the global target of ending AIDS as a public health threat increasingly out of reach.
Africa’s progress under pressure
The report presents Africa as both the region with the greatest HIV burden and one of the greatest public health success stories. Sub-Saharan Africa has recorded significant declines in new HIV infections over the past decade thanks to expanded access to treatment, prevention programmes and strong community health systems. Several countries have achieved the UNAIDS 95-95-95 targets, meaning that at least 95 percent of people living with HIV know their status, 95 percent of those diagnosed are receiving treatment, and 95 percent of those on treatment have achieved viral suppression.
However, the report warns that these gains are becoming increasingly fragile
Funding cuts have already disrupted HIV testing, prevention services and community-led programmes in several African countries. In some countries, access to PrEP has fallen sharply following reductions in donor support, raising concerns that new infections could increase if investments are not restored.
Against this backdrop, Rwanda stands out as one of Africa’s strongest performers
The country has achieved the UNAIDS 95-95-95 targets through sustained investment in community health workers, decentralized healthcare services, widespread HIV testing and universal access to treatment. Rwanda’s success demonstrates that ending AIDS is possible when strong political commitment is matched with consistent investment in health systems.
Like many countries in the region, its HIV response has benefited from long-standing international partnerships. As external funding becomes less predictable, sustaining progress will increasingly depend on strengthening domestic financing while maintaining support from development partners.
The latest UNAIDS report suggests that protecting the gains made over the past two decades will require governments to prioritize health financing even as they face competing economic pressures.
While the report paints a worrying picture, it also carries a message of hope
“Despite enormous challenges, ending AIDS is still within reach,” Byanyima said.
Her message reflects the report’s central conclusion: the science already exists to end AIDS. What is needed now is sustained political commitment and investment. For countries such as Rwanda, which have demonstrated that ambitious HIV targets are achievable, the challenge is no longer discovering new medicines but ensuring that existing services remain available to everyone who needs them.
The global HIV response has entered a new chapter. The question is no longer whether the world knows how to end AIDS, but whether it is willing to finance that future.